SniperFx

Archives

  • March 2023
  • February 2023
  • January 2023
  • September 2022
  • August 2022
  • January 2022
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019

Categories

  • Analysis
  • Bonds
  • COVID
  • Crypto
  • Forex
  • Forex Trading
  • Ideas
  • Investing
  • Stocks
  • Uncategorized
  • World
  • Home
  • Forex
  • Crypto
  • Contact
0 Likes
0 Followers
0 Followers
Subscribe
SniperFx
SniperFx
  • Bonds
  • Crypto
  • COVID
  • Forex
    • Forex Trading
  • Ideas
  • Investing
  • Stocks
  • World

Bayer sees lower profit, slower sales growth in 2023

  • admin
  • February 28, 2023
  • 2 minute read
Total
0
Shares
0
0
0

Bayer (ETR:BAYGN) said it expects revenue and profit to fall this year, as cost inflation, a rebound in the euro, and weaker demand combine to put a squeeze on the German conglomerate’s suite of products.

Bayer said it expects sales growth adjusted for foreign exchange and portfolio effects to grow by only 2%-3% to between €51 billion and €52 billion (€1 = $1.0585), as falling prices at its crop science division offset continued growth in pharma and consumer health.

“As regards earnings in 2023, growth-driven margin contributions and positive effects from ongoing efficiency programs will not be sufficient to offset the anticipated decline in prices as well as high inflation-driven cost increases, which are expected to continue,” chief executive Werner Baumann said.

Basic underlying earnings rose 21% last year to €13.5B, but are expected to fall to around €13B this year. Core earnings per share are expected to fall to €7.20-€7.40 from €7.94.

As always with Bayer, those underlying numbers are likely to be subject to big swings from one-off items as the company navigates its way through a forest of lawsuits related to the side effects of its Roundup weedkiller and the ongoing reshuffle of its product portfolio. Baumann has come under intense pressure from shareholders in recent years as Roundup litigation stopped the acquisition of Monsanto from delivering its promised benefits.

Litigation aside, crop sciences was the standout performer among Bayer’s three divisions last year, with earnings before interest, taxes, depreciation and amortization rising by 47% to €6.87 billion. However, momentum was already weakening in the fourth quarter, with EBITDA of €820 million a sharp slowdown from previous quarters.

At pharma, EBITDA before special items fell 4.8% from a year earlier in the fourth quarter to €4.86B, while consumer health EBITDA was essentially flat on the year at €313M.

Last week, the board offered activist shareholder Jeff Ubben, who is pressing for radical improvements in returns, a seat on its sustainability council, but has so far resisted offering him a seat on its supervisory board, which would give him greater influence.

Bayer stock reacted negatively to the weak outlook. By 03:25 ET (08:25 GMT), it was down 4% in Frankfurt at a four-week low.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
admin

Previous Article

EUR/CHF: Further upside pressure might arise, SNB could intervene – Commerzbank

  • admin
  • February 28, 2023
View Post
Next Article

Tesla’s Investor Day Could Lead to a DOGE Price Increase

  • admin
  • February 28, 2023
View Post
You May Also Like
View Post
  • Stocks

Adidas retracts opposition to Black Lives Matter three-stripe design

  • admin
  • March 29, 2023
View Post
  • Stocks

Starbucks, union at odds over hybrid negotiations

  • admin
  • March 28, 2023
View Post
  • Stocks

Novartis shares surge on positive results from key cancer drug trial

  • admin
  • March 27, 2023
View Post
  • Stocks

Standard Chartered agrees to sell business in Jordan

  • admin
  • March 26, 2023
View Post
  • Stocks

Britain’s John Lewis has lost its soul, says Mary Portas

  • admin
  • March 25, 2023
View Post
  • Stocks

Citigroup CEO declares ‘this is not a credit crisis’ after U.S. bank failures

  • admin
  • March 23, 2023
View Post
  • Stocks

First Republic Bank shares climb amid report of possible government backstop

  • admin
  • March 22, 2023
View Post
  • Stocks

EU court rules Mercedes must pay damages in diesel lawsuit

  • admin
  • March 21, 2023

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Taiwan president defiant after China threatens retaliation for US trip
  • Adidas retracts opposition to Black Lives Matter three-stripe design
  • XRP Price Prediction What to Expect in the Next 48 Hours
  • HelenP. I Euro break resistance 1.0800 and can continue to grow
  • Concerns about insufficiently decisive Riksbank would put SEK under downward pressure – Commerzbank

Recent Comments

No comments to show.
Featured Posts
  • 1
    Taiwan president defiant after China threatens retaliation for US trip
    • March 29, 2023
  • 2
    Adidas retracts opposition to Black Lives Matter three-stripe design
    • March 29, 2023
  • 3
    XRP Price Prediction What to Expect in the Next 48 Hours
    • March 29, 2023
  • 4
    HelenP. I Euro break resistance 1.0800 and can continue to grow
    • March 29, 2023
  • 5
    Concerns about insufficiently decisive Riksbank would put SEK under downward pressure – Commerzbank
    • March 29, 2023
Recent Posts
  • EUR/USD comes under pressure near 1.0850
    • March 29, 2023
  • Crypto Trader Firmly Believes ADA’s Next Target Could Be $0.60
    • March 29, 2023
  • Game-Changer Nasal Spray A Universal Shield Against All COVID-19 Variants
    • March 29, 2023
Categories
  • Analysis (12)
  • Bonds (50)
  • COVID (77)
  • Crypto (69)
  • Forex (85)
  • Forex Trading (50)
  • Ideas (50)
  • Investing (50)
  • Stocks (93)
  • Uncategorized (40)
  • World (199)
SniperFx
  • Home
  • Forex
  • Crypto
  • Contact
Forex & Crypto Updates

Input your search keywords and press Enter.